Evidence map›Paper›PMID 33454021›Full record

ReviewThe Journal of biological chemistry2020

Genetic diseases of the Kennedy pathways for membrane synthesis.

Mahtab Tavasoli, Sarah Lahire, Taryn Reid, Maren Brodovsky, Christopher R McMaster

Open access · hybridAbstract readReview
In one paragraph

Review in The Journal of biological chemistry, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
4.0field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 66 citations in OpenAlex.

  1. Preclinical efficacy of a gene therapy forMolecular therapy. Advances · 2026
    Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. A CHKA-PML autophagy checkpoint enables tumors to evade glutamine starvation.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. HCV NS3/4A protease relocalizes CCTα to viral replication sites, enhancing phosphatidylcholine synthesis and viral replication.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Mahtab TavasoliDepartment of Pharmacology, Dalhousie University, Halifax, Nova Scotia, Canada.
Sarah LahireUniversity of Reims Champagne-Ardenne, Reims, France.
Taryn ReidDepartment of Pharmacology, Dalhousie University, Halifax, Nova Scotia, Canada.
Maren BrodovskyDepartment of Pharmacology, Dalhousie University, Halifax, Nova Scotia, Canada.
Christopher R McMasterDepartment of Pharmacology, Dalhousie University, Halifax, Nova Scotia, Canada. Electronic address: christopher.mcmaster@dal.ca.
Dalhousie University · CAUniversité de Reims Champagne-Ardenne · FR

Funding

CIHR
6 · The paper itself

Abstract

The two branches of the Kennedy pathways (CDP-choline and CDP-ethanolamine) are the predominant pathways responsible for the synthesis of the most abundant phospholipids, phosphatidylcholine and phosphatidylethanolamine, respectively, in mammalian membranes. Recently, hereditary diseases associated with single gene mutations in the Kennedy pathways have been identified. Interestingly, genetic diseases within the same pathway vary greatly, ranging from muscular dystrophy to spastic paraplegia to a childhood blinding disorder to bone deformations. Indeed, different point mutations in the same gene (PCYT1; CCTα) result in at least three distinct diseases. In this review, we will summarize and review the genetic diseases associated with mutations in genes of the Kennedy pathway for phospholipid synthesis. These single-gene disorders provide insight, indeed direct genotype-phenotype relationships, into the biological functions of specific enzymes of the Kennedy pathway. We discuss potential mechanisms of how mutations within the same pathway can cause disparate disease.

Indexed as

AnimalsCholine KinaseCholine-Phosphate CytidylyltransferaseCytidine DiphosphateCytidine Diphosphate CholineEthanolaminesGenetic Association StudiesHumansMuscular DystrophiesOsteochondrodysplasiasPolymorphism, Single NucleotideCDP ethanolamineCHKB protein, humanCholine KinaseCholine-Phosphate CytidylyltransferaseCytidine DiphosphateCytidine Diphosphate CholineEthanolaminesPCYT1A protein, humangenetic diseaseinheritedlipidmembranemetabolismphosphatidylcholinephosphatidylethanolaminephospholipid

Identifiers

PMID33454021
PMCPMC7762932
OpenAlexW3094299673

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.